by
Barbara Kram, Editor | August 08, 2006
"Prognostic Stratification of Obese Patients by Stress 99mTc-Tetrofosmin Myocardial Perfusion Imaging" appears in the August issue of the Journal of Nuclear Medicine, which is published by SNM. Besides Elhendy, co-authors include Arend F.L. Schinkel, Ron T. van Domburg, Elena Biagini and Don Poldermans, all with Thoraxcenter, University Hospital Rotterdam, Rotterdam, the Netherlands; Jeroen J. Bax, Leiden University Hospital, the Netherlands; and Roelf Valkema, nuclear medicine department at the University Hospital Rotterdam, the Netherlands.
About SNM--Advancing Molecular Imaging and Therapy

Ad Statistics
Times Displayed: 19567
Times Visited: 365 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
SNM is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of molecular and nuclear imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed journal in the field (the Journal of Nuclear Medicine); host the premier annual meeting for medical imaging; sponsor research grants, fellowships and awards; and train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances. SNM members have introduced--and continue to explore--biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at www.snm.org.
Back to HCB News